RNASET2 and ovarian carcinoma: Moreover, RNASET2 protein has been reported to be targeted for FBXO6 unbiquitin-dependent protein degradation in ovarian cancer suggesting additional regulatory mechanism contribute to RNASET2 protein turnover (66).